| __timestamp | Ligand Pharmaceuticals Incorporated | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 55402000 | 580006000 |
| Thursday, January 1, 2015 | 66107000 | 676585000 |
| Friday, January 1, 2016 | 103402000 | 778966000 |
| Sunday, January 1, 2017 | 135736000 | 671251000 |
| Monday, January 1, 2018 | 245116000 | 463508000 |
| Tuesday, January 1, 2019 | 108935000 | 445724000 |
| Wednesday, January 1, 2020 | 156000000 | 399725000 |
| Friday, January 1, 2021 | 214957000 | 296656000 |
| Saturday, January 1, 2022 | 143418000 | 293122000 |
| Sunday, January 1, 2023 | 96265000 | 268323000 |
| Monday, January 1, 2024 | 304979000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, understanding financial health is crucial. This analysis delves into the gross profit trends of Ligand Pharmaceuticals Incorporated and Taro Pharmaceutical Industries Ltd. from 2014 to 2023. Over this period, Taro consistently outperformed Ligand, with gross profits peaking in 2016 at approximately 779 million, a staggering 650% higher than Ligand's peak in 2018. However, Taro's profits have shown a declining trend, dropping by 65% from 2016 to 2023. Ligand, on the other hand, experienced a more volatile journey, with a significant 340% increase from 2014 to 2018, followed by a 60% decline by 2023. Notably, data for Ligand in 2024 is missing, indicating potential reporting delays or strategic shifts. This comparative analysis highlights the dynamic nature of the pharmaceutical industry and the importance of strategic financial planning.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Pfizer Inc. and Taro Pharmaceutical Industries Ltd.
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Ligand Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Takeda Pharmaceutical Company Limited and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Biogen Inc. or Ligand Pharmaceuticals Incorporated
Key Insights on Gross Profit: Catalent, Inc. vs Ligand Pharmaceuticals Incorporated
Exelixis, Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Trends
Who Generates Higher Gross Profit? Grifols, S.A. or Taro Pharmaceutical Industries Ltd.
Key Insights on Gross Profit: Veracyte, Inc. vs Ligand Pharmaceuticals Incorporated
Gross Profit Comparison: Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. Trends